?
Kerr James
EVP and CFO
The Gorman-Rupp Company
US, Mansfield [HQ]
CIK
1371010
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
24,356
Price per Share :
$37.66
Equivalence :
$917,246.96
Transaction History
-
F24,356 Shares After TransactionValue : $672,712.72$5,662.10Transaction Date : 02/24/23
-
Footnotes
-
-
Footnotes:#1 Shares withheld for payment of tax liability on vesting of 684 restricted stock units.#2 Includes 4,166 restricted stock units granted under The Gorman-Rupp Company 2015 Omnibus Incentive Plan, which vest between February 2024 and February 2026.
-
A26,833 Shares After TransactionValue : $n/a$0.0Transaction Date : 02/22/24
-
Footnotes
-
-
Footnotes:#1 Represents restricted stock units granted under the Company's shareholder approved equity plan, which vest in annual installments over a three-year vesting period.#2 Shares withheld for payment of tax liability on vesting of 932 restricted stock units.#3 Performance-based shares awarded under the Company's shareholder approved equity plan after achieving specific performance goals over the 2022-2023 performance period, which vest on December 31, 2024.#4 Shares withheld for payment of tax liability on vesting of 684 restricted stock units.#5 Balance includes 5,027 unvested restricted stock units granted under the Company's shareholder approved equity plan, which vest between February 2025 and February 2027.
-
F26,555 Shares After TransactionValue : $n/a$0.0Transaction Date : 02/22/24
-
Footnotes
-
-
Footnotes:#1 Represents restricted stock units granted under the Company's shareholder approved equity plan, which vest in annual installments over a three-year vesting period.#2 Shares withheld for payment of tax liability on vesting of 932 restricted stock units.#3 Performance-based shares awarded under the Company's shareholder approved equity plan after achieving specific performance goals over the 2022-2023 performance period, which vest on December 31, 2024.#4 Shares withheld for payment of tax liability on vesting of 684 restricted stock units.#5 Balance includes 5,027 unvested restricted stock units granted under the Company's shareholder approved equity plan, which vest between February 2025 and February 2027.
-
A33,950 Shares After TransactionValue : $n/a$0.0Transaction Date : 02/22/24
-
Footnotes
-
-
Footnotes:#1 Represents restricted stock units granted under the Company's shareholder approved equity plan, which vest in annual installments over a three-year vesting period.#2 Shares withheld for payment of tax liability on vesting of 932 restricted stock units.#3 Performance-based shares awarded under the Company's shareholder approved equity plan after achieving specific performance goals over the 2022-2023 performance period, which vest on December 31, 2024.#4 Shares withheld for payment of tax liability on vesting of 684 restricted stock units.#5 Balance includes 5,027 unvested restricted stock units granted under the Company's shareholder approved equity plan, which vest between February 2025 and February 2027.
-
F33,746 Shares After TransactionValue : $n/a$0.0Transaction Date : 02/24/24
-
Footnotes
-
-
Footnotes:#1 Represents restricted stock units granted under the Company's shareholder approved equity plan, which vest in annual installments over a three-year vesting period.#2 Shares withheld for payment of tax liability on vesting of 932 restricted stock units.#3 Performance-based shares awarded under the Company's shareholder approved equity plan after achieving specific performance goals over the 2022-2023 performance period, which vest on December 31, 2024.#4 Shares withheld for payment of tax liability on vesting of 684 restricted stock units.#5 Balance includes 5,027 unvested restricted stock units granted under the Company's shareholder approved equity plan, which vest between February 2025 and February 2027.